Gastric and Esophageal Cancer Drugs Market- Drivers

Increasing number of cancer drugs in pipeline studies and rising involvement of key players for development of cancer treatment are expected to propel gastric and esophageal cancer drugs market growth. For instance, in April 2016, Centre Hospitalier Universitaire de Besancon, initiated Phase 1 and Phase 2 clinical trial for Carboplatin to determine the maximum tolerated dose (MTD) and recommended doses for phase II (RP2D) by considering the treatment scheme of Dutch study for chemotherapy and radiotherapy. The study is conducted in elderly patients with esophagus cancer. Carboplatin is an anticancer chemotherapy drug from alkylating agent category. The study is estimated to complete by April 2024.

Moreover, in February 2017, Henan Cancer Hospital in collaboration with Jiangsu HengRui Medicine Co., Ltd., initiated Phase 2 exploratory clinical trial to evaluate the efficacy of Apatinib, treatment for advanced esophagus cancer. Apatinib is a tyrosine kinase inhibitor that selectively inhibits the vascular endothelial growth factor receptor-2(VEGFR2).

However, high cost of therapy for the treatment of gastric and esophageal cancers is expected to restraint the market growth. For instance, as per the report published in Healthday, in 2013, cancer patients paid US$ 207,000 a year for the treatment and medications while in 1995 the cost was US$ 54,100 a year.

Request Sample Free Copy of Report here: https://www.coherentmarketinsights.com/insight/request-sample/2438

Download PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2438

Gastric and Esophageal Cancer Drugs Market- Regional Analysis

On the basis of region, the global gastric and esophageal cancer drugs market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Geographically, North America is expected to be the leading region in the gastric and esophageal cancer drugs market during the forecast period, owing to high prevalence of esophageal cancer in this region. For instance, the American Cancer Society’s estimated that about 17,650 new esophageal cancer cases in the U.S. will be diagnosed (13,750 in men and 3,900 in women) by 2019. Moreover, mergers and acquisitions activities by key players in this region are expected to propel the market growth during the forecast period. For instance, in December 2018, GlaxoSmithKline plc announced the acquisition of TESARO Inc, an oncology focused company based in Massachusetts, U.S. This acquisition is expected to strengthen GSK’s pharmaceutical business by accelerating GSK’s pipeline and commercial capability in oncology.

Key players in Europe are focused on various business strategies such as acquisitions and mergers, which in turn boosts growth of the market. For instance, in September 2018, Boehringer Ingelheim acquired all shares of ViraTherapeutics, an Austria-based biopharmaceutical company, specializing in the development of oncolytic viral therapies. The total transaction value for this acquisition was US$ 240.52 million. This acquisition strengthened Boehringer Ingelheim’s commitment to research and development for viral-based immuno-oncology treatment.

Key players for gastric and esophageal cancer drugs market includes Amgen, Eli Lilly and Company, F. Hoffmann-La Roche, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Bristol-Myers Squibb, GlaxoSmithKline Plc., Novartis AG, Johnson & Johnson, Gilead Sciences, Merck & Co. and others.

Gastric and Esophageal Cancer Drugs Market- Taxonomy

By Therapy Type

• Chemotherapy
• Targeted Therapy
• Immunotherapy

By Disease Indication

• Adenocarcinomas
• Gastrointestinal Stromal Tumors
• Carcinoid Tumors
• Squamous Cell Carcinoma
• Others

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa

Buy now the market research report here:https://www.coherentmarketinsights.com/insight/buy-now/2438

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. 

What we provide:

• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

Explore CMI Services here

Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Source: https://www.coherentmarketinsights.com/ongoing-insight/gastric-and-esophageal-cancer-drugs-market-2438

Market Dynamics

Increasing geriatric population prone to major life threatening diseases such as cancer, chronic diseases, and neurological disorders is a major factor driving elderly nutrition market growth. World Health Organization Prospectus, 2017, estimated a significant rise in geriatric population above 60 years, from 962 million in 2017 to reach 2.1 billion by 2050, and tis increase will triple in 2100, globally.

Moreover, rising number of government initiatives program regarding nutrition and diet are expected to boost the market growth. For instance, in September 2017, the Government of Tanzania launched National Multi-sectoral Nutrition Action Plan (NMNAP) for 2016-2021, to address malnutrition problems for development of nutrition level in healthcare sector. The Nutrition International’s Technical Assistance in Nutrition actively partnered with government of Tanzania for this project.

However, side effects and complications observed in parenteral therapy leads to serious and life threating condition such as refeeding syndrome, liver dysfunction. For instance, Journal of Gastroenterology and Hepatology, December 2013, estimated around 50% cases of refeeding syndrome by physicians from the study conducted in New Zealand.

Request Sample Free Copy of Report here: https://www.coherentmarketinsights.com/insight/request-sample/2437

Download PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2437

Key features of the study:

• This report provides in-depth analysis of the elderly nutrition market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the global elderly nutrition market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include, Otsuka Pharmaceuticals Co., Ltd., Baxter International Inc., Allergan, Danone, Abbott Laboratories, Pfizer, Inc., Mead Johnson & Company, LLC., Sanofi, Nestlé’s, GlaxoSmithKline, Wockhardt Ltd, Fresenius Kabi AG, and Ranbaxy
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
• The global elderly nutrition market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the elderly nutrition market

Detailed Segmentation:

• Global Elderly Nutrition Market, By Nutrition Type:
• Minerals
• Multi-Vitamins
• Iron
• Proteins
• Fibers
• Lipids
• Antioxidants
• Others
• Global Elderly Nutrition Market, By Application:
• Diabetes
• Renal Failures
• Obesity
• Sarcopenia
• Cancer
• Others
• Global Elderly Nutrition Market, By Route of Administration:
• Oral
• Parenteral
• Enteral
• Global Elderly Nutrition Market, By Distribution Channel:
• Hospitals & Clinics
• Retail Pharmacies
• Convenience Store
• Online
• Others
• Global Elderly Nutrition Market, By Geography:
• North America
• By Nutrition Type:
• Minerals
• Multi-Vitamins
• Iron
• Proteins
• Fibers
• Lipids
• Antioxidants
• Others
• By Application:
• Diabetes
• Renal Failures
• Obesity
• Sarcopenia
• Cancer
• Others
• By Route of Administration:
• Oral
• Parenteral
• Enteral
• By Route of Distribution Channel:
• Hospitals & Clinics
• Retail Pharmacies
• Convenience Store
• Online
• Others
• By Country:
• U.S.
• Canada
• Latin America
• By Nutrition Type:
• Minerals
• Multi-Vitamins
• Iron
• Proteins
• Fibers
• Lipids
• Antioxidants
• Others
• By Application:
• Diabetes
• Renal Failures
• Obesity
• Sarcopenia
• Cancer
• Others
• By Route of Administration:
• Oral
• Parenteral
• Enteral
• By Route of Distribution Channel:
• Hospitals & Clinics
• Retail Pharmacies
• Convenience Store
• Online
• Others
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Nutrition Type:
• Minerals
• Multi-Vitamins
• Iron
• Proteins
• Fibers
• Lipids
• Antioxidants
• Others
• By Application:
• Diabetes
• Renal Failures
• Obesity
• Sarcopenia
• Cancer
• Others
• By Route of Administration:
• Oral
• Parenteral
• Enteral
• By Route of Distribution Channel:
• Hospitals & Clinics
• Retail Pharmacies
• Convenience Store
• Online
• Others
• By Country:
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Nutrition Type:
• Minerals
• Multi-Vitamins
• Iron
• Proteins
• Fibers
• Lipids
• Antioxidants
• Others
• By Application:
• Diabetes
• Renal Failures
• Obesity
• Sarcopenia
• Cancer
• Others
• By Route of Administration:
• Oral
• Parenteral
• Enteral
• By Route of Distribution Channel:
• Hospitals & Clinics
• Retail Pharmacies
• Convenience Store
• Online
• Others
• By Country:
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Nutrition Type:
• Minerals
• Multi-Vitamins
• Iron
• Proteins
• Fibers
• Lipids
• Antioxidants
• Others
• By Application:
• Diabetes
• Renal Failures
• Obesity
• Sarcopenia
• Cancer
• Others
• By Route of Administration:
• Oral
• Parenteral
• Enteral
• By Route of Distribution Channel:
• Hospitals & Clinics
• Retail Pharmacies
• Convenience Store
• Online
• Others
• By Country:
• GCC
• Israel
• Rest of Middle East
• Africa
• By Nutrition Type:
• Minerals
• Multi-Vitamins
• Iron
• Proteins
• Fibers
• Lipids
• Antioxidants
• Others
• By Application:
• Diabetes
• Renal Failures
• Obesity
• Sarcopenia
• Cancer
• Others
• By Route of Administration:
• Oral
• Parenteral
• Enteral
• By Route of Distribution Channel:
• Hospitals & Clinics
• Retail Pharmacies
• Convenience Store
• Online
• Others
• By Country:
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Otsuka Pharmaceuticals Co., Ltd. *
• Company Overview
• Product Portfolio
• Financial Performance
• Key Highlights
• Market Strategies
• CONMED Corporation
• Baxter International Inc.
• Allergan
• Danone
• Abbott Laboratories
• Pfizer, Inc.
• Mead Johnson & Company, LLC.
• Sanofi
• Nestlé’s
• GlaxoSmithKline
• Fresenius Kabi AG
• Ranbaxy

“*” marked represents similar segmentation in other categories in the respective section.

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. 

What we provide:

• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

Explore CMI Services here

Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Source: https://www.coherentmarketinsights.com/market-insight/elderly-nutrition-market-2437

Dental Wound Dressings Market Driver

Increasing incidences of dental surgeries and root canal treatments are expected to boost the dental wound dressing market growth. For instance, as per Data from the National Health and Nutrition Examination Survey, for 2015–2016, the prevalence of total caries (untreated and treated) in the U.S. was 45.8% and untreated caries was 13.0% among youth aged 2–19 years. Moreover, in 2017, Capstone Clintonville Dentist surveyed that, around 15 million root canal procedures were performed in the U.S. annually.

Request Sample Free Copy of Report here: https://www.coherentmarketinsights.com/insight/request-sample/2436

Download PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2436

Dental Wound Dressings Market Restraints

However, high cost of the dental surgeries is limiting the patient’s inflow in the clinics and it is expected to hamper the dental wound dressing market growth. For instance, in 2014, Canadian Academy of Health Sciences stated that Canadians spend around US$ 12 billion annually on dental services, but six million people annually avoid dentists due to high cost of dental services.

Dental Wound Dressings Market Regional Analysis

On the basis of region, the dental wound dressings market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to witness significant growth in the dental wound dressing market, owing to increasing clinical trials in this region. For instance, in 2017, Medtech Startup Axio Biosolutions announced the positive results for the clinical trial of axiostat dental haemostatic dressing in patients on oral antiplatelet drugs. The study has been designed to evaluate the efficacy of Axiostat Dental Haemostatic Dressing for post extraction methods.

Europe is also expected to show significant growth for the dental wound dressings market over the forecast period, owing to increase in approvals for the products. For instance, in September 2016, NovaBone Products, a private biologics medical device company, received CE mark approval in the European Union for NovaTape and NovaPlug, dental wound dressing products. The new products are used to manage dental sores, oral ulcers, periodontal surgical wounds, suture sites, burns, extraction sites, surgical, and traumatic wounds.

Key players for dental wound dressings market include Sabra Dental Products., Collagen Matrix, Inc., 3M sciences Cologenesis Healthcare Pvt. Ltd., Kerr Dental., Axio Biosolutions Private Limited, Zimmer Biomet, and Novabone.

Dental Wound Dressings Market Taxonomy

By Dressing Type

• Oxidized regenerated cellulose
• Whitehead’s varnish
• Carnoy’s solution
• Bismuth iodoform paraffin paste
• Zinc oxide-based dressings
• Alvogyl
• Collagen

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa

Buy now the market research report here:https://www.coherentmarketinsights.com/insight/buy-now/2436

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. 

What we provide:

• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

Explore CMI Services here

Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Source: https://www.coherentmarketinsights.com/ongoing-insight/dental-wound-dressings-market-2436

Dental Caries Market- Drivers

Increasing number of pipeline studies to develop treatments for dental caries is expected to boost the dental caries market growth. For instance, in February 2017, Oral Health Centre of Expertise in Eastern Norway in collaboration with Public Dental Service from Ostfold, Oppland, and Hedmark, announced the post market surveillance (Phase 4) for fluoride varnishes and fissure sealants to evaluate its effectiveness in a pragmatic randomized clinical trial. Fluoride varnish is a highly concentrated form of fluoride used to apply on tooth's surface and fissure sealants are used to prevent tooth decay. The study is expected to be completed in December 2022.

Dental Caries Market- Restraints

However, the side effects associated with dental caries treatment and failure of the treatment, owing to lack of knowledge of the operators is expected to hamper growth of the dental caries market. For instance, in April 2015, as per study report by Department of Conservative Dentistry, College of Dentistry, University of Aljouf, KSA, the failure rate of endodontic treatment performed by the general dental practitioners (GDPs) was 78.8%. The factors responsible for endodontic failures were underfilled canals (33.3%), unfilled, and missed canals (17.7%).

Request Sample Free Copy of Report here: https://www.coherentmarketinsights.com/insight/request-sample/2435

Download PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2435

Dental Caries Market- Regional Analysis

On the basis of region, the global dental caries market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to boost the dental caries market share, owing to increasing number of pipeline studies in this region. In November 2017, Virginia Commonwealth University initiated the clinical study on device, OpalSeal, for evaluation of protective effects of Opalseal against early dental decay in orthodontic patients. Opalseal is a fluoride-releasing primer that reduces cavities in patients using braces.

Moreover, increasing number of pipeline studies to develop treatment for dental caries is also driving growth of the market in this region. For instance, in October 2018, University of Michigan in collaboration with three other universities, New York University School of Medicine, University of Iowa, and National Institute of Dental and Craniofacial Research (NIDCR), initiated phase 3 clinical trial for Silver Diamine Fluoride. The aim of study was to evaluate the effectiveness of Silver Diamine Fluoride (Sdf) in arresting cavitated caries lesions. The study is expected to be completed in June 2020.

New product launches by key players in Asia Pacific region is expected to drive growth of Asia Pacific dental caries market. For instance, in 2015, Colgate-Palmolive Singapore launched new toothpaste for cavity prevention technology. The toothpaste contains sugar acid neutralizer, which neutralizes the sugar acids before they can harm the teeth. Moreover, the toothpaste also helps in preventing cavity formation by reducing demineralization, and strengthen and restore the tooth enamel.

Key players operating in the dental caries market include Sanofi, Bayer AG, Eli Lilly and Company, Bristol-Myers Squibb, Merck & Co, Inc., AstraZeneca Plc, Dr.Reddy’s Lab, Novartis AG., Dentsply Sirona Inc., 3M Company, Danaher Corporation, Zimmer Inc., Straumann AG, and Henry-Schein Inc.

Dental Caries Market- Taxonomy

By Treatment Type

• Fluoride Treatments
• Composite Tooth Fillings
• Dental Crowns
• Root Canal
• Extraction

By End User

• Hospitals
• Dental Clinics
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa

Buy now the market research report here:https://www.coherentmarketinsights.com/insight/buy-now/2435

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. 

What we provide:

• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

Explore CMI Services here

Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Source: https://www.coherentmarketinsights.com/ongoing-insight/dental-caries-market-2435

Central Nervous System Biomarkers Market – Drivers

Increasing number of pipeline studies for the development of biomarkers in various disease conditions is expected to boost the central nervous system biomarkers marketgrowth. For instance, in March 1, 2017, Hospices Civils de Lyon, initiated the clinical trial to evaluate predictive value of CSF biomarkers of Alzheimer’s disease (AD) in geriatric patients with new-onset epilepsy.

Biomarkers are becoming crucial in drug discovery and development process. Therefore, increasing number of research for drug development is also expected to propel the central nervous system biomarkers market growth. For instance, in January 2016, The Tufts Center for the Study of Drug Development, estimated that the developing cost of a new drug was US$ 2.6 billion and also suggested that the costs of drug development are increasing at a compound annual growth rate of 8.5%.

However, high cost of validation process such as sample collection & storage and unfavorable reimbursement situation for development and discovery of biomarkers can impede the central nervous system biomarkers market growth.

 Request Sample Free Copy of Report here: https://www.coherentmarketinsights.com/insight/request-sample/2434

Download PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2434

Central Nervous System Biomarkers Market – Regional Analysis

On the basis of region, the global central nervous system biomarkers market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America central nervous system biomarkers market is expected to show significant growth, owing to expansion activities by key players in the region. For Instance, in January 2017, bioMérieux, an in vitro diagnostics company, entered into a partnership with Banyan Biomarkers. Banyan Biomarkers develops, validate, and market blood-based biomarkers for traumatic brain injury. Under this agreement, bioMérieux took an equity participation of around US$ 7 million in Banyan Biomarkers and also obtained rights to develop market for Banyan’s proprietary tests worldwide.

Increasing prevalence of Alzheimer’s disease is expected to drive growth for the central nervous system biomarkers market in Asia Pacific. For instance, according to Alzheimer's Disease International (ADI), in 2015, around 23 million people in Asia Pacific suffered from dementia.

Keys players operating in the global central nervous system biomarkers market include, Thermo fisher scientific, Enzo Biochem Inc., Abiant Inc., EKF Diagnostics Holdings Inc., Abastar MDX Inc., Acumen Pharmaceuticals Inc., Adlyfe Inc., Apitope International, Alseres Pharmaceuticals Inc., Aposense, Banyan Biomarkers, Avid Radiopharmaceuticals Inc., Diagenic ASA, Avacta Group plc., Applied Neurosolutions Inc., Merc & Co. Inc., and Exonhit Therapeutics.

Central Nervous System Biomarkers Market – Taxonomy

By Application

• Drug Discovery & Development
• Personalized Medicines
• Disease Risk Assessment
• Diagnostics

By Disease Indication

• Alzheimer’s Disease
• Multiple Sclerosis
• Parkinson’s Disease
• Traumatic Brain Injury
• Other Neurological Conditions

By End User

• Diagnostic Labs
• Clinics/Hospitals
• Research Centers

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa

Buy now the market research report here:https://www.coherentmarketinsights.com/insight/buy-now/2434

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. 

What we provide:

• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

Explore CMI Services here

Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Source: https://www.coherentmarketinsights.com/ongoing-insight/central-nervous-system-biomarkers-market-2434

Canine Arthritis Market – Drivers

Factors such as high adoption of pets by common people, increasing expenditure by consumers on veterinary care, and increasing number of approvals for veterinary medicines are expected to drive growth of the canine arthritis market. For instance, in March 2016, USFDA approved Galliprant — an animal drug for osteoarthritis in dogs. Galliprant is a prostaglandin E2 (PGE2) EP4 receptor antagonist, a non-cyclooxygenase inhibiting, non-steroidal anti-inflammatory drug (NSAID) and is intended to control pain and inflammation associated with osteoarthritis in dogs. The application for Galliprant was sponsored by Aratana Therapeutics.

Furthermore, increasing initiatives by professional business services to offer support for pet care is expected to propel the market growth. For instance, in January 2019, the International Boarding & Pet Services Association (IBPSA) appointed one Chief Operating Officer along with three new advisory boards to bring an additional and invaluable experiences of pet care business to IBPSA and its members.

However, side effects associated with canine arthritis treatments are expected to hamper growth of the canine arthritis market.

Request Sample Free Copy of Report here: https://www.coherentmarketinsights.com/insight/request-sample/2433

Download PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2433

Canine Arthritis Market – Regional Analysis

On the basis of region, the global canine arthritis market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected witness significant growth in the global canine arthritis market, owing to presence of major players and new product launches in the region. For instance, in July 2018, CBD DOG Health — a pet wellness company — launched three new products containing healing cannabinoids at the SuperZoo Pet Industry Trade Show in Las Vegas, U.S. The three new products include, lines of CBD Oils, CBD Topicals, and CBD Treats. CBD Oil offers products namely CALM, EASE, and HEAL varieties. It contains full spectrum hemp oil and CBD. EASE Oil is a proprietary blend of curcumin-rich Turmeric and Frankincense. It offers relief from aches and pains, inflammation, joint pain, arthritis, and intestinal disorders in pets.

Moreover, increasing adoption of pets in North America is also expected to boost growth of the canine arthritis market. For instance, in 2017-2018, National Pet Owners Survey was conducted by Ipsos, Inc., and according to the survey, pet ownership in the U.S. households stands at 68% as compared to 48% in 2016.

Key players operating in the global canine arthritis market include, Elanco (Eli Lilly and Company), Boehringer Ingelheim, Zoetis Inc., Vetoquinol S.A., Bayer AG, Aratana Therapeutics Inc., Norbrook Laboratories Limited, VetStem Biopharma, and Dechra Pharmaceuticals Plc., and CBD DOG Health.

Canine Arthritis Market – Taxonomy

By Medication Type

• Non-Steroidal Anti-Inflammatory Drugs (NSAID’s)
• Corticosteroids
• Opioid Pain Relievers
• Others

By Distribution Channel

• Veterinary Hospitals & Clinics
• Retail Pharmacies
• Online Pharmacies

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa

Buy now the market research report here:https://www.coherentmarketinsights.com/insight/buy-now/2433

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. 

What we provide:

• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

Explore CMI Services here

Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S

Phone: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Source: https://www.coherentmarketinsights.com/ongoing-insight/canine-arthritis-market-2433

Bovine Blood Plasma Derivatives Market- Drivers

Increasing use of bovine blood plasma derivatives in biopharmaceutical companies for cell culture technique, biotechnology, and research and development is expected to drive the market growth. For Instance, in November 2018, Wageningen University initiated the preclinical trial for Bovine plasma protein powder to assess the protein digestion kinetics and protection of the epithelial barriers including other markers for identification of gastrointestinal health, metabolic health, and vascular health, and satiating properties.

Bovine Blood Plasma Derivatives Market - Restraints

Availability of prominent alternatives to bovine blood plasma derivatives is expected to hamper the market growth. For Instance, in April 2015, Rocky Mountain Biologicals, Inc. – a life science and bioprocessing company — launched high-performance Fetal Bovine Serum alternative — Fetalgro. Fetalgro is proprietary blend of a calf serum base and proprietary additives that matches the Fetal Bovine Serum’s (FBS) cell growth capabilities in CHO, MRC-5, Vero, and a wide range of other cell lines.

 Request Sample Free Copy of Report here: https://www.coherentmarketinsights.com/insight/request-sample/2432

Download PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2432

Bovine Blood Plasma Derivatives Market - Regional Analysis

On the basis of region, the global bovine plasma derivatives market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to witness significant market growth over the forecast period. Key players in the region are focused on adopting merger and acquisition strategies in order to expand their geographical presence, which in turn is expected to contribute to growth of the market in North America. For Instance, in August 2018, LAMPIRE Biological Laboratories acquired 180+ acre corporate dairy farms located adjacent to the existing corporate farm facilities in Bedford County, Pennsylvania. The acquisition has been made to expand its operations and establishments in the western part of Pennsylvania. By this acquisition, LAMPIRE Biological Laboratories intended to offer valuable biological raw materials to diagnostic and research companies around the world.

Furthermore, Asia Pacific is expected witness significant growth in the market over the forecast period. Market growth in the region is attributed to government initiatives and approvals to export products such as cattle protein and serum. For Instance, in June 2017, Government of China approved formal access for bovine blood products from New Zealand in the market in China. The approval was passed by the General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China. Under the approval, the Ministry for Primary Industries New Zealand gave access to sixteen manufacturing plants to export products such as cattle protein and serum to China.

Key players operating in the global bovine blood plasma derivatives market include, Proliant Inc., Bovogen Biologicals Pty Ltd., LAMPIRE Biological Laboratories, Inc., Rocky Mountain Biologicals Inc., Thermo Fisher Scientific, Inc., Sigma-Aldrich Co. (Merck KGaA), Kraeber & Co GmbH, Auckland BioSciences Ltd., and Lake Immunogenics, Inc.

Bovine Blood Plasma Derivatives Market - Taxonomy

By Derivatives Type

• Immunoglobulin
• Fibrinogen
• Serum Albumin
• Fetal Bovine Serum
• Thrombin
• Transferrin
• New Born Calf Serum
• Others

By Application

• Pharmaceutical Industry
• Diagnostics Industry
• Cell Culture/ Biotechnology
• Research and Development
• Food Industry
• Cosmetic Industry

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa

 Buy now the market research report here:https://www.coherentmarketinsights.com/insight/buy-now/2432

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. 

What we provide:

• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

Explore CMI Services here

Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Source: https://www.coherentmarketinsights.com/ongoing-insight/bovine-blood-plasma-derivatives-market-2432

Automatic Stair Climbing Wheelchair Market Driver

Increasing initiatives by the major players to develop innovative products is expected to fuel automatic stair climbing wheelchair market growth. For instance, in 2017, a team in Zurich introduced the Scewo. Scewo is self-balancing stair climbing wheelchair that can go up and down stairs independently and smoothly and provides features useful for navigating over obstacles. By using multiple rubber tracks, it can provide smooth and safe ride on the stairs. Furthermore, in 2015, a team in Zurich launched the Scalevo, the original prototype consist of two big wheels with a Segway-styled balancing system to navigate flat ground.

However, high cost of the automatic stair climbing wheelchairs is expected to hamper the market growth. For instance, in 2003, the subsidiary firm by Johnson Company in USA developed IBOT, a stair climbing wheelchair. The price of IBOT was so high that most of people could not afford it and it was discontinued in 2009.

Request Sample Free Copy of Report here: https://www.coherentmarketinsights.com/insight/request-sample/2431

Download PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2431

Automatic Stair Climbing Wheelchair Market Regional Analysis

On the basis of region, the global automatic stair climbing wheelchair market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Geographically, North America region is expected to hold the largest market share for automatic stair climbing wheelchair market, owing to rising number of people with disabilities in the US. For instance, in 2016, American Community Survey (ACS), estimated that rate of people with disabilities in the U.S. population was 12.8%. The percentage of people with a disability has increased from 11.9% in 2010, to 12.8% in 2016.

Moreover, Asia Pacific is anticipated to witness significant growth in automatic stair climbing wheelchair market attributed to presence of major players in this region. For instance, in May 2016, Toyota, the automobile company, joined Kamen's company DEKA, to support mobility solutions for the disabled community. This agreement was made to develop and launch the next generation of the IBOT. The IBOT motorized wheelchair was launched back in 2001, by Segway inventor Dean Kamen. However, the price of IBOT was US$ 25,000 which was too expensive for the mainstream market resulting into discontinuation of device in 2009.

Key players for automatic stair climbing wheelchair market include TopChair, B-Free Technology Limited, Toyota, designboom, Vin Grace Solutions (P) Ltd., and Johnson and Johnson.

Automatic Stair Climbing Wheelchair Market Taxonomy

By Mode of Operation

• Manual
• Powered

By End User

• Hospitals
• Rehabilitation Centers
• Home Care Settings
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa

Buy now the market research report here:https://www.coherentmarketinsights.com/insight/buy-now/2431

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. 

What we provide:

• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

Explore CMI Services here

Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Source: https://www.coherentmarketinsights.com/ongoing-insight/automatic-stair-climbing-wheelchair-market-2431

Atherosclerosis Treatment Drugs Market - Driver

Increasing number of pipeline studies and rising involvement of key players for developing the treatment options for atherosclerosis are expected to propel atherosclerosis treatment drugs market growth. For Instance, in November 13, 2018, Bayer in collaboration with Janssen, LP started the clinical study for Rivaroxaban and Acetylsalicylic Acid to build up the insights in treatment patterns and to study results of Rivaroxaban (Xarelto) in combination with acetylsalicylic acid (xatoa) prescribed to patients with atherosclerosis. The study is estimated to complete in August 2021.

Moreover, technological advancement in the atherosclerosis treatment procedures is expected to boost the atherosclerosis treatments drug market growth. For instance, in May 2017, Researchers at Ben-Gurion University (BGU) and the Sheba Medical Center developed Nano polymer therapy, a new therapy for the treatment of atherosclerosis. It prevents heart failure with a new biomedical polymer (E-selectin-targeting polymer) that reduces arterial plaque and inflammation in the cardiovascular system. E-selectin-targeting polymer helps to reduce existing plaque and impedes the further plaque formation. It also prevents arterial thrombosis, ischemia, myocardial infarction, and strokes.

Request Sample Free Copy of Report here: https://www.coherentmarketinsights.com/insight/request-sample/2430

Download PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2430

Atherosclerosis Treatment Drugs Market- Restraints

However, the side effects associated with atherosclerosis drugs and limited efficacy of the drugs is expected to hamper atherosclerosis market growth. For instance, in November 2016, The Lancet led by Rory Collins, provided an evidence on statin therapy and the methodological limitations. As per data, statins are associated with increased incidence of diabetes and hemorrhagic stroke. Statins tends to increase the risk of type 2 diabetes in a dose-dependent mode.

Atherosclerosis Treatment Drugs Market- Regional Analysis

On the basis of region, the global atherosclerosis treatment drugs market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Geographically, North America is expected to gain significant market share over the forecast period, owing to increasing incidences of atherosclerotic condition among the population in this region. For instance, in November 2016, as per data provided by the U.S. Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), there were more than 15.5 million Americans who had coronary artery disease and it is expected that for every 42 seconds an American will experience the onset of a myocardial infarction.

Furthermore, Asia Pacific is expected to witness significant growth in the market, owing to expansion of major key players in this region. For instance, in October 2017, GSK opened its new regional headquarters for Asia in Singapore. The GSK’s purpose for building headquarters is to support the pharmaceutical, vaccines, and consumer healthcare businesses across multiple regions in Asia Pacific.

Key players operating in the Atherosclerosis treatment drugs market include GlaxoSmithKline plc. Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Isis Pharmaceuticals, Inc., Anthera Pharmaceuticals, Novartis AG, Sanofi, Johnson and Johnson, Bayer AG, The Medicine Company, and Cardium Therapeutics.

Atherosclerosis Treatment Drugs Market- Taxonomy

By Drugs Type

• Cholesterol medications
• Beta Blockers
• Angiotensin-converting enzyme (ACE) Inhibitors
• Calcium Channel blocker
• Diuretics
• Antiplatelet
• Other Medications

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa

Buy now the market research report here:https://www.coherentmarketinsights.com/insight/buy-now/2430

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. 

What we provide:

• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

Explore CMI Services here

Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Source: https://www.coherentmarketinsights.com/ongoing-insight/atherosclerosis-treatment-drugs-market-2430

Market Dynamics

Advantages offered by laser indirect ophthalmoscope over conventional ophthalmoscope is expected to drive growth of the  laser indirect ophthalmoscope market over the forecast period. Moreover, increasing need of basic as well as diagnostic eye examinations of various ophthalmic disorders such as retinal holes or tears, retinal detachment, lattice degeneration, retinoschisis, and sickle cell retinopathy is fuelling demand for basic ophthalmic diagnostic equipments such as indirect ophthalmoscope. Advantages offered by indirect ophthalmoscope include wide field of view, examination of periphery of retina, and others. These factors are expected to fuel growth of the laser indirect ophthalmoscope market over the forecast period.

Request Sample Free Copy of Report here: https://www.coherentmarketinsights.com/insight/request-sample/2428

Download PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2428

Key features of the study:

• This report provides in-depth analysis of laser indirect ophthalmoscope market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2018–2026), considering 2017 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global laser indirect ophthalmoscope market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
• Key companies covered as a part of this study include Ellex Medical Lasers Ltd, Iridex Corporation, Alcon, Carl Zeiss Meditec AG, Lumenis Ltd., Topcon Medical Laser System, Nidek Co. Inc., Ziemer Ophthalmic Systems AG, Heine Optotechnik GmbH, and Keeler Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, by technology up-gradation, market expansion, and marketing tactics
• The global laser indirect ophthalmoscope market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the laser indirect ophthalmoscope market

Detailed Segmentation:

• Global Laser Indirect Ophthalmoscope Market, By Laser Type:
• Photocoagulating laser
• Photo disrupting laser
• Photo ablating laser
• Global Laser Indirect Ophthalmoscope Market, By Therapeutic Application:
• Diabetic retinopathy
• Peripheral neovascularization
• Lattice degeneration
• Others
• Global Laser Indirect Ophthalmoscope Market, By End User:
• Multispecialty Hospitals
• Ophthalmic Clinics
• Others
• Global Laser Indirect Ophthalmoscope Market, By Region:
• North America
• By Laser Type:
• Photocoagulating laser
• Photo disrupting laser
• Photo ablating laser
• By Therapeutic Application:
• Diabetic retinopathy
• Peripheral neovascularization
• Lattice degeneration
• Others
• By End User:
• Multispecialty Hospitals
• Ophthalmic Clinics
• Others
• By Country:
• U.S.
• Canada
• Europe
• By Laser Type:
• Photocoagulating laser
• Photo disrupting laser
• Photo ablating laser
• By Therapeutic Application:
• Diabetic retinopathy
• Peripheral neovascularization
• Lattice degeneration
• Others
• By End User:
• Multispecialty Hospitals
• Ophthalmic Clinics
• Others
• By Country:
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Laser Type:
• Photocoagulating laser
• Photo disrupting laser
• Photo ablating laser
• By Therapeutic Application:
• Diabetic retinopathy
• Peripheral neovascularization
• Lattice degeneration
• Others
• By End User:
• Multispecialty Hospitals
• Ophthalmic Clinics
• Others
• By Country:
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• By Laser Type:
• Photocoagulating laser
• Photo disrupting laser
• Photo ablating laser
• By Therapeutic Application:
• Diabetic retinopathy
• Peripheral neovascularization
• Lattice degeneration
• Others
• By End User:
• Multispecialty Hospitals
• Ophthalmic Clinics
• Others
• By Country:
• Brazil
• Mexico
• Rest of Latin America
• Middle East
• By Laser Type:
• Photocoagulating laser
• Photo disrupting laser
• Photo ablating laser
• By Therapeutic Application:
• Diabetic retinopathy
• Peripheral neovascularization
• Lattice degeneration
• Others
• By End User:
• Multispecialty Hospitals
• Ophthalmic Clinics
• Others
• By Country:
• GCC
• Israel
• Rest of Middle East
• Africa
• By Laser Type:
• Photocoagulating laser
• Photo disrupting laser
• Photo ablating laser
• By Therapeutic Application:
• Diabetic retinopathy
• Peripheral neovascularization
• Lattice degeneration
• Others
• By End User:
• Multispecialty Hospitals
• Ophthalmic Clinics
• Others
• By Country:
• Central Africa
• South Africa
• North Africa
• Company Profiles
• Ellex Medical Lasers Ltd *
• Company Overview
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Iridex Corporation
• Alcon
• Carl Zeiss Meditec AG
• Lumenis Ltd.
• Topcon Medical Laser Systems
• Nidek Co. Inc.
• Ziemer Ophthalmic Systems AG
• Heine Optotechnik GmbH
• Keeler Ltd.

“*” marked represents similar segmentation in other categories in the respective section.

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. 

What we provide:

• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

Explore CMI Services here

Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Source: https://www.coherentmarketinsights.com/market-insight/laser-indirect-ophthalmoscope-market-2428